Profil
Derzeit bekleidet Matthew Charles Perrins Hammond die Position des Managing Director & Chief Financial Officer bei Mail.ru Group Ltd. Herr Hammond ist außerdem Mitglied des Vorstands von Strike Resources Ltd. (Australien) und PuriCore, Inc. In der Vergangenheit war er Group Strategist bei Metalloinvest Holding Co. JSC und Technologieanalyst bei Credit Suisse Securities (Europe) Ltd. Herr Hammond erwarb einen Bachelor-Abschluss an der University of Bristol.
Aktive Positionen von Matthew Hammond
| Unternehmen | Position | Beginn |
|---|---|---|
Realm Therapeutics, Inc.
Realm Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ESSA Pharma, Inc., Realm Therapeutics, Inc. is a company that specializes in precision brain stimulation therapies to address memory loss caused by brain injury and degenerative diseases such as Alzheimer's. The company is based in Radnor, PA. The company's technology, developed at the University of Pennsylvania with DARPA funding, aims to enhance memory, reduce disability, and boost productivity for patients. By utilizing artificial intelligence to analyze brain activity patterns, the company's device delivers personalized stimulation to improve memory performance. The company is currently in the preclinical testing phase and is preparing for FDA approval to conduct clinical trials for patients with memory loss from traumatic brain injury. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Matthew Hammond
| Unternehmen | Position | Ende |
|---|---|---|
| STRIKE RESOURCES LIMITED | Direktor/Vorstandsmitglied | 27.09.2024 |
Quanergy Perception Technologies, Inc.
Quanergy Perception Technologies, Inc. Aerospace & DefenseElectronic Technology Develops and manufactures light detection and sensors & dimensional sensing solutions | Direktor/Vorstandsmitglied | 30.09.2022 |
| VK COMPANY LIMITED | Vorstandsvorsitzender | 13.12.2021 |
| REALM THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 17.11.2017 |
| QIWI PLC | Direktor/Vorstandsmitglied | 29.09.2014 |
Ausbildung von Matthew Hammond
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Strike Resources Ltd. (Australia)
Strike Resources Ltd. (Australia) SteelNon-Energy Minerals Engages in the exploration and evaluation of iron ore projects | Non-Energy Minerals |
Realm Therapeutics Plc
Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops proprietary immunomodulatory products | Health Technology |
Quanergy Perception Technologies, Inc.
Quanergy Perception Technologies, Inc. Aerospace & DefenseElectronic Technology Develops and manufactures light detection and sensors & dimensional sensing solutions | Electronic Technology |
Credit Suisse Securities (Europe) Ltd.
Credit Suisse Securities (Europe) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nautilus Minerals, Inc.
Nautilus Minerals, Inc. Precious MetalsNon-Energy Minerals Engages in the exploration of ocean floor for copper, gold, silver and zinc deposits activities | Non-Energy Minerals |
QIWI Plc
QIWI Plc Miscellaneous Commercial ServicesCommercial Services Provides payment processing services | Commercial Services |
VK International PJSC
VK International PJSC Internet Software/ServicesTechnology Services Operates communication and social platforms | Technology Services |
Realm Therapeutics, Inc.
Realm Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ESSA Pharma, Inc., Realm Therapeutics, Inc. is a company that specializes in precision brain stimulation therapies to address memory loss caused by brain injury and degenerative diseases such as Alzheimer's. The company is based in Radnor, PA. The company's technology, developed at the University of Pennsylvania with DARPA funding, aims to enhance memory, reduce disability, and boost productivity for patients. By utilizing artificial intelligence to analyze brain activity patterns, the company's device delivers personalized stimulation to improve memory performance. The company is currently in the preclinical testing phase and is preparing for FDA approval to conduct clinical trials for patients with memory loss from traumatic brain injury. | Commercial Services |
















